UBS reiterates Buy rating on Ulta Beauty stock with $680 price target

UBS reiterated its Buy rating on Ulta Beauty (ULTA) with a $680 price target, citing strong leadership performance, improved operations, and strategic brand partnerships expected to drive continued positive earnings revisions. This follows Ulta's Q2 comparable sales growth of 6.7%, exceeding expectations, and its expansion into Mexico. With the stock trading near its 52-week high, the positive analyst sentiment, also echoed by DA Davidson and Piper Sandler, underscores market confidence in Ulta's strategic growth and favorable industry dynamics.

Analysis

Ulta Beauty (ULTA) has received a reiterated 'Buy' rating and a $680 price target from UBS, signaling strong confidence in the company's trajectory. This bullish stance is underpinned by the effective execution of a new leadership team, which has translated into tangible performance metrics, including a second-quarter comparable sales increase of 6.7%, surpassing the consensus estimate of approximately 5%. This growth was well-balanced, driven by a 3.7% rise in transactions and a 2.9% increase in average ticket size. Strategically, Ulta is strengthening its competitive position through exclusive brand partnerships and has initiated its international expansion with its first stores in Mexico. The positive outlook is further supported by a moderating pace of new competition in the prestige beauty sector and a broad analyst consensus, with DA Davidson and Piper Sandler also reaffirming 'Buy' and 'Overweight' ratings, respectively. However, it is noteworthy that the stock is trading near its 52-week high of $559.41, and an InvestingPro analysis suggests it is currently priced above its Fair Value, indicating high market expectations are already factored in.

Key Decisions for Investors

• Given the strong operational momentum and unanimous positive analyst ratings, investors could view any price pullbacks as potential entry points, aligning with the significant upside implied by UBS's $680 price target.
• Investors should exercise caution regarding valuation, as the stock is trading near its 52-week high and is noted to be above its intrinsic fair value, suggesting much of the positive outlook may already be priced in.
• Monitor future earnings reports for sustained comparable sales growth and evidence that the revamped brand partnership strategy and Mexican expansion are contributing positively to the top and bottom lines, which would be necessary to justify further multiple expansion.